129 related articles for article (PubMed ID: 1847389)
1. Efficient purification of recombinant human tumor necrosis factor beta from Escherichia coli yields biologically active protein with a trimeric structure that binds to both tumor necrosis factor receptors.
Schoenfeld HJ; Poeschl B; Frey JR; Loetscher H; Hunziker W; Lustig A; Zulauf M
J Biol Chem; 1991 Feb; 266(6):3863-9. PubMed ID: 1847389
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
Andrews JS; Berger AE; Ware CF
J Immunol; 1990 Apr; 144(7):2582-91. PubMed ID: 1969453
[TBL] [Abstract][Full Text] [Related]
3. Purification and renaturation of recombinant human lymphotoxin (tumour necrosis factor beta) expressed in Escherichia coli as inclusion bodies.
Jin H; Uddin MS; Huang YL; Teo WK
J Chem Technol Biotechnol; 1994 Jan; 59(1):67-72. PubMed ID: 7764497
[TBL] [Abstract][Full Text] [Related]
4. Induction of receptors for tumor necrosis factor-alpha by interferons is not a major mechanism for their synergistic cytotoxic response.
Aggarwal BB; Eessalu TE
J Biol Chem; 1987 Jul; 262(21):10000-7. PubMed ID: 2440858
[TBL] [Abstract][Full Text] [Related]
5. [Preparation of lymphotoxin and properties of it].
Lebedev LR; Pustoshilova NM; Sinichkina SA; Andreeva IS
Prikl Biokhim Mikrobiol; 1998; 34(1):120-6. PubMed ID: 9566293
[TBL] [Abstract][Full Text] [Related]
6. [Recombinant human lymphotoxin: synthesis in Escherichia coli cells, purification, and certain properties].
Denisov AA; Torskiĭ SP; Nikolaeva OG; Volozhantseva IIa
Biokhimiia; 1995 Sep; 60(9):1403-10. PubMed ID: 8562649
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha, but not lymphotoxin, stimulates growth of tumor cells in hairy cell leukemia.
Buck C; Digel W; Schöniger W; Stefanic M; Ragnavachar A; Heimpel H; Porzsolt F
Leukemia; 1990 Jun; 4(6):431-4. PubMed ID: 2162999
[TBL] [Abstract][Full Text] [Related]
8. Diversity of the effect of recombinant tumor necrosis factors alpha and beta on human myelogenous leukemia cell lines.
Beran M; Andersson BS; Kelleher P; Whalen K; McCredie K; Gutterman J
Blood; 1987 Mar; 69(3):721-6. PubMed ID: 3028534
[TBL] [Abstract][Full Text] [Related]
9. Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activity.
Loetscher H; Gentz R; Zulauf M; Lustig A; Tabuchi H; Schlaeger EJ; Brockhaus M; Gallati H; Manneberg M; Lesslauer W
J Biol Chem; 1991 Sep; 266(27):18324-9. PubMed ID: 1655744
[TBL] [Abstract][Full Text] [Related]
10. Modulation of receptors and cytotoxic response of tumor necrosis factor-alpha by various lectins.
Aggarwal BB; Traquina PR; Eessalu TE
J Biol Chem; 1986 Oct; 261(29):13652-6. PubMed ID: 3020039
[TBL] [Abstract][Full Text] [Related]
11. A tumor necrosis factor binding protein is present in human biological fluids.
Peetre C; Thysell H; Grubb A; Olsson I
Eur J Haematol; 1988 Nov; 41(5):414-9. PubMed ID: 2850215
[TBL] [Abstract][Full Text] [Related]
12. Characterization and affinity cross-linking of receptors for human recombinant lymphotoxin (tumor necrosis factor-beta) on a human histiocytic lymphoma cell line, U-937.
Stauber GB; Aggarwal BB
J Biol Chem; 1989 Feb; 264(6):3573-6. PubMed ID: 2536752
[TBL] [Abstract][Full Text] [Related]
13. Biochemical characterization of the extracellular domain of the 75-kilodalton tumor necrosis factor receptor.
Pennica D; Lam VT; Weber RF; Kohr WJ; Basa LJ; Spellman MW; Ashkenazi A; Shire SJ; Goeddel DV
Biochemistry; 1993 Mar; 32(12):3131-8. PubMed ID: 8384489
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a relationship between the T-lymphocyte derived differentiation inducing factor (DIF) and lymphotoxin: a common receptor system for DIF, lymphotoxin and tumor necrosis factor downregulated by phorbol diesters.
Gullberg U; Lantz M; Nilsson E; Peetre C; Adolf G; Olsson I
Eur J Haematol; 1987 Sep; 39(3):241-51. PubMed ID: 2824237
[TBL] [Abstract][Full Text] [Related]
15. Effect of phorbol esters on down-regulation and redistribution of cell surface receptors for tumor necrosis factor-alpha.
Aggarwal BB; Eessalu TE
J Biol Chem; 1987 Dec; 262(34):16450-5. PubMed ID: 2824494
[TBL] [Abstract][Full Text] [Related]
16. Comparison of recombinant tumor necrosis factor and the monocyte-derived cytotoxic factor involved in monocyte-mediated cytotoxicity.
Nissen-Meyer J; Austgulen R; Espevik T
Cancer Res; 1987 May; 47(9):2251-8. PubMed ID: 3567918
[TBL] [Abstract][Full Text] [Related]
17. The effects of human recombinant tumor necrosis factor on glioma-derived cell lines: cellular proliferation, cytotoxicity, morphological and radioreceptor studies.
Rutka JT; Giblin JR; Berens ME; Bar-Shiva E; Tokuda K; McCulloch JR; Rosenblum ML; Eessalu TE; Aggarwal BB; Bodell WJ
Int J Cancer; 1988 Apr; 41(4):573-82. PubMed ID: 2833452
[TBL] [Abstract][Full Text] [Related]
18. Characterization of recombinant human lymphotoxin (tumor necrosis factor-beta) produced by a mammalian cell line.
Hains JM; Aggarwal BB
Arch Biochem Biophys; 1989 Nov; 274(2):417-25. PubMed ID: 2802619
[TBL] [Abstract][Full Text] [Related]
19. A 63 kDa tumor necrosis factor inhibitor released from a human monocytic leukemia cell line, THP-1.
Aso H; Yoshite O; Tomioka Y; Rose MT; Mizugaki M
Microbiol Immunol; 1999; 43(1):53-9. PubMed ID: 10100747
[TBL] [Abstract][Full Text] [Related]
20. Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha.
Shalaby MR; Palladino MA; Hirabayashi SE; Eessalu TE; Lewis GD; Shepard HM; Aggarwal BB
J Leukoc Biol; 1987 Mar; 41(3):196-204. PubMed ID: 3031189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
